| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P2093 | author name string | L R Sutherland | |
| G R May | |||
| P G Godet | |||
| P2860 | cites work | Meta-analysis in clinical trials | Q27860779 |
| Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction | Q34043306 | ||
| Quantitative methods in the review of epidemiologic literature | Q34187297 | ||
| Evidence for an increased risk of Crohn's disease in oral contraceptive users | Q34200100 | ||
| Chronic inflammatory bowel disease, cigarette smoking, and use of oral contraceptives: findings in a large cohort study of women of childbearing age | Q34285270 | ||
| The existence of publication bias and risk factors for its occurrence | Q34373168 | ||
| Colonic Crohn's disease and use of oral contraception. | Q34555819 | ||
| Epidemiology of Crohn's Disease. | Q39308631 | ||
| Differences in risk estimations from a hospital and a population-based case-control study | Q39352134 | ||
| Factors influencing first relapse in patients with Crohn's disease | Q39604033 | ||
| Evanescent colitis | Q40355906 | ||
| Effect of oral contraceptive use on reoperation following surgery for Crohn's disease | Q41108821 | ||
| Two cheers for meta-analysis: problems and opportunities in aggregating results of clinical trials | Q42593071 | ||
| Chronic inflammatory bowel disease, cigarette smoking and use of oral contraceptives | Q43173234 | ||
| Oral contraceptive use and cigarette smoking in Crohn's disease | Q43527336 | ||
| Vascular occlusion of the colon and oral contraceptives. Possible relation | Q44029617 | ||
| Risk indicators for inflammatory bowel disease | Q44632586 | ||
| Colonic Crohn's disease and oral contraceptive (author's transl) | Q66851284 | ||
| Crohn's disease after administration of oral contraceptives. Report of a case (author's transl) | Q67776736 | ||
| Oral Contraceptive Use and the Risk of Inflammatory Bowel Disease | Q68222262 | ||
| Lack of association between oral contraceptive use and ulcerative colitis | Q68903817 | ||
| Lack of association between oral contraceptive use and Crohn's disease: a community-based matched case-control study | Q69384930 | ||
| Possibility of selection bias in matched case-control studies using friend controls | Q69535259 | ||
| Inflammatory bowel disease in oral contraceptive users | Q69546520 | ||
| Oral contraception, smoking and inflammatory bowel disease--findings in the Royal College of General Practitioners Oral Contraception Study | Q69612297 | ||
| Oral contraceptives and Crohn's disease | Q70015860 | ||
| Estrogen- and progesterone-associated colitis: a disorder with clinical and endoscopic features mimicking Crohn's colitis | Q70600188 | ||
| [Intestinal complications during the use of oral contraceptives] | Q94142518 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meta-analysis | Q815382 |
| inflammation | Q101991 | ||
| inflammatory bowel diseases | Q917447 | ||
| P304 | page(s) | 668-673 | |
| P577 | publication date | 1995-11-01 | |
| P1433 | published in | Gut | Q5621669 |
| P1476 | title | Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease | |
| P478 | volume | 37 |
| Q77091149 | 10 Adjuvant post-operative therapy |
| Q35598234 | Antibiotic use and the development of Crohn's disease |
| Q38127583 | Aryl hydrocarbon receptor and colitis |
| Q37122211 | Breastfeeding and genetic factors in the etiology of inflammatory bowel disease in children |
| Q37899835 | Challenges associated with identifying the environmental determinants of the inflammatory bowel diseases. |
| Q34480355 | Crohn's Disease and Mycobacterium avium subsp. paratuberculosis: Current Issues |
| Q82248961 | Crohn's disease in people exposed to clinical cases of bovine paratuberculosis |
| Q38008983 | Drug-induced inflammatory bowel disease and IBD-like conditions. |
| Q37723798 | Environmental influences on the onset and clinical course of Crohn's disease-part 2: infections and medication use. |
| Q39593826 | Environmental risk factors and Crohn's disease: a population-based, case-control study in Spain |
| Q33916393 | Environmental risk factors for inflammatory bowel disease |
| Q63284654 | Environmental risk factors in Crohn's disease and ulcerative colitis: an update |
| Q51677583 | Epidemiology of Crohn's disease in Québec, Canada |
| Q34538014 | Etiopathogenesis of inflammatory bowel disease: the importance of the pediatric perspective |
| Q35068954 | Familial aggregation in inflammatory bowel disease: is it genes or environment? |
| Q40039972 | Hormonal contraception and the development of autoimmunity: A review of the literature |
| Q34987163 | Incidence and clinical course of Crohn's disease during the first year - results from the IBD Cohort of the Uppsala Region (ICURE) of Sweden 2005-2009. |
| Q34222244 | Inflammatory bowel disease and asthma: a population-based, case-control study |
| Q34745633 | Inflammatory bowel disease and environmental influences |
| Q73122636 | Inflammatory bowel disease in pregnancy |
| Q84593979 | Inflammatory bowel disease in the elderly |
| Q33284507 | Inflammatory bowel disease: cause and immunobiology |
| Q63284680 | Les facteurs d’environnement dans la maladie de Crohn et la rectocolite hémorragique (tabac et appendicectomie exclus) |
| Q35947785 | Oral Contraceptives and Multiple Sclerosis/Clinically Isolated Syndrome Susceptibility |
| Q50883754 | Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group |
| Q35356341 | Oral contraceptive use and the clinical course of Crohn's disease: a prospective cohort study |
| Q34338435 | Pre-illness isoflavone consumption and disease risk of ulcerative colitis: a multicenter case-control study in Japan |
| Q39963574 | Risk factors for ulcerative colitis: A population-based, case–control study in Spain |
| Q56227068 | Risk factors in German twins with inflammatory bowel disease: Results of a questionnaire-based survey |
| Q44199053 | Role of genetic and environmental factors in British twins with inflammatory bowel disease |
| Q51025821 | Sex Differences in Experimentally Induced Colitis in Mice: a Role for Estrogens |
| Q34410437 | Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect |
| Q77349083 | Sulfur metabolism in ulcerative colitis: investigation of detoxification enzymes in peripheral blood |
| Q56243557 | The association between new generation oral contraceptive pill and the development of inflammatory bowel diseases |
| Q30935480 | The epidemiology of IBD: a lot of data but little knowledge. How shall we proceed? |
| Q38733734 | The impact of inflammatory bowel disease on oral health. |
| Q35141666 | The role of estrogen signaling in a mouse model of inflammatory bowel disease: a Helicobacter hepaticus model |
| Q36277417 | Thrombosis and inflammatory bowel disease |
| Q36636016 | What is the origin of ulcerative colitis? Still more questions than answers |
Search more.